A detailed history of Bare Financial Services, Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bare Financial Services, Inc holds 30 shares of BMRN stock, worth $1,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 58 48.28%
Holding current value
$1,641
Previous $3.19 Million 49.03%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$52.62 - $61.93 $1,473 - $1,734
-28 Reduced 48.28%
30 $1.63 Million
Q2 2025

Aug 13, 2025

BUY
$54.08 - $68.32 $2,974 - $3,757
55 Added 1833.33%
58 $3.19 Million
Q1 2025

May 12, 2025

BUY
$61.25 - $72.83 $183 - $218
3 New
3 $212,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.